2016
DOI: 10.1038/jhg.2016.55
|View full text |Cite
|
Sign up to set email alerts
|

Genotyping NUDT15 can predict the dose reduction of 6-MP for children with acute lymphoblastic leukemia especially at a preschool age

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
21
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(23 citation statements)
references
References 23 publications
1
21
0
1
Order By: Relevance
“…Importantly, many investigators have been able to replicate these results in studies of thiopurine-treated patients with IBD or ALL 789101112131415161718. In the current study, we successfully established a significant association between NUDT15 p.Arg139Cys and thiopurine-induced leukopenia and severe hair loss.…”
Section: Discussionsupporting
confidence: 56%
See 1 more Smart Citation
“…Importantly, many investigators have been able to replicate these results in studies of thiopurine-treated patients with IBD or ALL 789101112131415161718. In the current study, we successfully established a significant association between NUDT15 p.Arg139Cys and thiopurine-induced leukopenia and severe hair loss.…”
Section: Discussionsupporting
confidence: 56%
“…The high specificity and sensitivity (89.4% and 93.2%, respectively) of NUDT15 p.Arg139Cys recorded by these authors indicate that this variant, rather than TPMT polymorphisms, may be an effective genetic marker for predicting thiopurine-induced adverse events, at least in East Asian populations. To date, this strong association has been confirmed in numerous studies involving subjects with IBD or ALL 789101112131415161718. In addition, a further investigation identified 4 NUDT15 coding variants, including p.Arg139Cys, that influence both nucleotide diphosphatase activity and levels of thiopurine active metabolites, and found loss-of-function NUDT15 variants to be associated with thiopurine intolerance 13.…”
Section: Introductionmentioning
confidence: 74%
“…normal) for TPMT still develop toxicity that necessitates MP dose reduction or protocol interruption . Recently, several studies reported on an inherited nucleoside diphosphate‐linked moiety X motif 15 ( NUDT15 ) c.415C>T (rs116855232) nonsynonymous (R139C) low‐function variant that is associated with decreased thiopurine metabolism and leukopenia in ALL and other diseases . This allele and a few others in the same gene are most common among individuals of Asian ancestry, with the initial susceptibility to thiopurine‐related leucopenia being reported in a cohort of Korean subjects with Crohn disease .…”
Section: Introductionmentioning
confidence: 99%
“…[ 20 – 23 ] Besides, other studies in children with acute lymphoblastic leukemia (ALL) have recognized that the NUDT15 R139C variant increased the risk of developing thiopurine-induced toxicity ( P < .00001) and identified a variant in NUDT15 R139C gene to be associated with intolerance of thiopurine dose. [ 17 , 24 – 26 ] Suzuki et al [ 27 ] found that NUDT15 R139C genotyping could be beneficial in estimating the tolerated dose of 6-MP for Japanese patients with childhood ALL, particularly during the preschool age (younger than 7 years) ( P = .04). Furthermore, the variant frequency of NUDT15 R139C showed ethnic variability: 9.8% in East Asians, 4.1% in Hispanics, 0.2% in Europeans, and 0.0% in Africans.…”
Section: Literature Review and Discussionmentioning
confidence: 99%